These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 6405619

  • 21. [Treatment of hyperprolactinemic conditions with bromoergocryptine].
    Sas M, Godó G, Morvay J.
    Zentralbl Gynakol; 1978; 100(22):1501-7. PubMed ID: 570784
    [Abstract] [Full Text] [Related]

  • 22. Therapeutic use of bromocriptine in women with amenorrhea-galactorrhea and suspected pituitary microadenoma.
    Jewelewicz R.
    Adv Biochem Psychopharmacol; 1980; 23():209-15. PubMed ID: 7395612
    [No Abstract] [Full Text] [Related]

  • 23. Treatment of women with the galactorrhea-amenorrhea syndrome with pyridoxine (vitamin B6).
    McIntosh EN.
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1192-5. PubMed ID: 945301
    [Abstract] [Full Text] [Related]

  • 24. Use of brom-ergocryptine in treating amenorrhea/galactorrhea.
    Shapiro AG.
    South Med J; 1977 Jun; 70(6):720-1, 725. PubMed ID: 577621
    [Abstract] [Full Text] [Related]

  • 25. Treatment of functional amenorrhea-galactorrhea with 2-bromoergocryptine.
    Wiebe RH, Hammond CB, Handwerger S.
    Fertil Steril; 1977 Apr; 28(4):426-33. PubMed ID: 321260
    [Abstract] [Full Text] [Related]

  • 26. Treatment of galactorrhea-amenorrhea syndrome with 2-Br-alpha-ergocryptin (CB 154). Clinical response and pattern of pituitary and steriod hormones before and during therapy.
    Künzig HJ, Geiger W, Schulz KD, Lose KH.
    Arch Gynakol; 1975 Apr; 218(2):85-94. PubMed ID: 1174026
    [Abstract] [Full Text] [Related]

  • 27. The natural history of idiopathic hyperprolactinemia.
    Martin TL, Kim M, Malarkey WB.
    J Clin Endocrinol Metab; 1985 May; 60(5):855-8. PubMed ID: 3980670
    [Abstract] [Full Text] [Related]

  • 28. Bromocriptine mesylate (Parlodel) in the management of amenorrhea/galactorrhea associated with hyperprolactinemia.
    Cuellar FG.
    Obstet Gynecol; 1980 Mar; 55(3):278-84. PubMed ID: 6987580
    [Abstract] [Full Text] [Related]

  • 29. Pregnancy following 2-bromo-alpha-ergocryptine (CB-154)-induced ovulation in an acromegalic patient with galactorrhea and amenorrhea.
    Aono T, Shioji T, Kohno M, Ueda G, Kurachi K.
    Fertil Steril; 1976 Mar; 27(3):341-4. PubMed ID: 943332
    [Abstract] [Full Text] [Related]

  • 30. Neurogenic galactorrhea-amenorrhea.
    Boyd AE, Spare S, Bower B, Reichlin S.
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1374-7. PubMed ID: 263659
    [Abstract] [Full Text] [Related]

  • 31. [Study on galactorrhea-amenorrhea syndrome (GAS) with special reference to normoprolactinemic GAS].
    Imai T, Yasuda K, Miura K.
    Nihon Naibunpi Gakkai Zasshi; 1988 Jan 20; 64(1):1-15. PubMed ID: 3132404
    [Abstract] [Full Text] [Related]

  • 32. Amenorrhea and galactorrhea: results of therapy with 2-Brom-alpha-ergocryptine (CB-154).
    Lloyd SJ, Josimovich JB, Archer DF.
    Am J Obstet Gynecol; 1975 May 01; 122(1):85-9. PubMed ID: 1168997
    [Abstract] [Full Text] [Related]

  • 33. [Use of bromocriptine to induce ovulation in the galactorrhea-amenorrhea syndrome [].
    Hernández Ayup S, Muñoz M, González R, Galache P, Guitrón A, Pancardo RM, Forsbach G.
    Rev Invest Clin; 1982 May 01; 34(2):121-3. PubMed ID: 7123023
    [No Abstract] [Full Text] [Related]

  • 34. Effect of bromocriptine on patients with hyperprolactinemia and amenorrhea.
    Meduri M, Deodato M, Bramanti P, Volpe A, Grasso A, Di Perri R.
    Acta Neurol (Napoli); 1980 Feb 01; 2(1):15-22. PubMed ID: 7190350
    [No Abstract] [Full Text] [Related]

  • 35. Prolactin responsiveness to TRH in amenorrheic women with and without galactorrhea.
    MacGregor C, Maldonado D, Canales ES, Soria J, Zárate A.
    Acta Obstet Gynecol Scand; 1977 Feb 01; 56(4):333-6. PubMed ID: 414510
    [Abstract] [Full Text] [Related]

  • 36. Editorial: Galactorrhea-amenorrhea, brom-ergocryptine, and the dopamine receptor.
    Boyd AE, Reighlin S.
    N Engl J Med; 1975 Aug 28; 293(9):451-2. PubMed ID: 1171365
    [No Abstract] [Full Text] [Related]

  • 37. The significance of galactorrhea in patients with normal menses, oligomenorrhea, and secondary amenorrhea.
    Davajan V, Kletzky O, March CM, Roy S, Mishell DR.
    Am J Obstet Gynecol; 1978 Apr 15; 130(8):894-904. PubMed ID: 565142
    [Abstract] [Full Text] [Related]

  • 38. Prolactin and thyrotropin responses to thyrotropin-releasing hormone in patients with secondary amenorrhea: the effect of bromocriptine.
    Hirvonen E, Ranta T, Seppäla M.
    J Clin Endocrinol Metab; 1976 Jun 15; 42(6):1024-30. PubMed ID: 819453
    [Abstract] [Full Text] [Related]

  • 39. Bromocriptine in the treatment of hyperolactinemic amenorrhea.
    Badano AR, Miechi HR, Mirkin A, Arcángeli OA, Aparicio NJ, Rodríguez A, Oliva A, Turner D, Figueroa Casas PR.
    Fertil Steril; 1979 Feb 15; 31(2):124-9. PubMed ID: 570131
    [Abstract] [Full Text] [Related]

  • 40. Long-term follow-up of women with amenorrhea-galactorrhea treated with bromocriptine.
    Tartagni M, Nicastri PL, Diaferia A, Di Gesù I, Loizzi P.
    Clin Exp Obstet Gynecol; 1995 Feb 15; 22(4):301-6. PubMed ID: 8777784
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.